| Document Date: 2014-11-03 11:26:20 Open Document File Size: 90,34 KBShare Result on Facebook
City Houston / Osaka / / Company Shionogi Inc. / AEs / Shionogi & Co. Ltd. / Japan Shionogi & Co. / Blue Bird Circle Clinic / / Country United States / / / Event Product Issues / FDA Phase / / Facility Texas Children’s Hospital / Blue Bird Circle Clinic / / IndustryTerm liquid solution / machinery / pharmaceutical / / MedicalCondition glaucoma / pathologic drooling / urinary retention / neurological disorders / Cuvposa Constipation / nausea / hyperthyroidism / drowsiness / cardiac tachyarrhythmias / disorder / renal disease / tachycardia / diarrhea / coronary heart disease / constipation / severe ulcerative colitis / mechanical intestinal obstruction / myasthenia gravis / chronic severe drooling / toxic megacolon / cerebral palsy / congestive heart failure / problem drooling / hypertension / cancer / disease / flushing / candidiasis / nasal congestion / Intestinal pseudoobstruction / fever / allergy / paralytic ileus / Metabolic Syndrome / About Chronic Severe Drooling Sialorrhea / ulcerative colitis / pain / vomiting / Cerebral Palsy Cerebral palsy / drooling / neurologic disorders / neuromuscular dysfunction / hiatal hernia / Infectious Diseases / tardive dyskinesia / toxic megacolon complicating ulcerative colitis / moderate-to-severe drooling / dehydration / / Organization U.S. Food and Drug Administration / Texas Children’s Hospital / / Person Jennifer Davidson / Robert S. Zeller / Monique Kelley / DO / Yoshimasa Kyokawa / / / Position investigator / lead study investigator / medical director / modified Teacher / director / / Product potassium chloride / haloperidol / glycopyrrolate / Crestor / digoxin / atenolol / CUVPOSA® (glycopyrrolate) oral / United States / work / / ProvinceOrState Texas / / URL www.shionogi.co.jp / www.fda.gov/medwatch / www.shionogi.com / www.CUVPOSA.com / /
SocialTag |